<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this study was to investigate the contribution of the <z:chebi fb="0" ids="29101">Na(+)</z:chebi>/<z:chebi fb="0" ids="15378">H(+)</z:chebi> exchanger to <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> using SM-20220 (N-(aminoiminomethyl)-1-<z:chebi fb="36" ids="29309">methyl</z:chebi>-1H-<z:chebi fb="0" ids="35581">indole</z:chebi>-2-<z:chebi fb="0" ids="23004,37622">carboxamide</z:chebi> <z:chebi fb="0" ids="25224">methanesulfonate</z:chebi>), a newly synthesized compound </plain></SENT>
<SENT sid="1" pm="."><plain>In in vitro experiments, we evaluated the inhibitory effect of SM-20220 on the <z:chebi fb="0" ids="29101">Na(+)</z:chebi>/<z:chebi fb="0" ids="15378">H(+)</z:chebi> exchanger in cultured neurons and glial cells </plain></SENT>
<SENT sid="2" pm="."><plain>The IC(50) of SM-20220 in neurons and glial cells was 5 nM and 20 nM, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>To examine the in vivo effects of SM-20220 on brain injury, we used a transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model in rats </plain></SENT>
<SENT sid="4" pm="."><plain>SM-20220 given intravenously 1 h after occlusion significantly reduced the extent of <z:hpo ids='HP_0002181'>cerebral edema</z:hpo>, <z:chebi fb="0" ids="29101">Na(+)</z:chebi> content and infarcted area in a dose-dependent manner </plain></SENT>
<SENT sid="5" pm="."><plain>The results of the present study suggest that the <z:chebi fb="0" ids="29101">Na(+)</z:chebi>/<z:chebi fb="0" ids="15378">H(+)</z:chebi> exchanger is involved in the aggravation of <z:hpo ids='HP_0002181'>brain edema</z:hpo> and infarction, and its inhibitor may exert protective effects on post-ischemic brain damage </plain></SENT>
</text></document>